Journal
FRONTIERS IN NEUROLOGY
Volume 13, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fneur.2022.830614
Keywords
intracerebral hemorrhage (ICH); health technology assessment (HTA); cost-effectiveness analysis; neurosurgery; minimally invasive surgery (MIS)
Categories
Funding
- Netherlands Cardiovascular Research Initiative
- Dutch Heart Foundation [CVON2015-01, T2019T060, 015008048]
- Brain Foundation Netherlands [2012T077]
- ZonMw (ASPASIA) [HA2015.01.06]
- Dutch Research Council [91818617]
Ask authors/readers for more resources
In patients with spontaneous supratentorial intracerebral hemorrhage, innovative minimally invasive neurosurgery has the potential to be cost-effective, even with relatively low effectiveness. Further research on the effectiveness of MIS is supported.
BackgroundIn patients with spontaneous supratentorial intracerebral hemorrhage (ICH), open craniotomy has failed to improve a functional outcome. Innovative minimally invasive neurosurgery (MIS) may improve a health outcome and reduce healthcare costs. AimsBefore starting phase-III trials, we aim to assess conditions that need to be met to reach the potential cost-effectiveness of MIS compared to usual care in patients with spontaneous supratentorial ICH. MethodsWe used a state-transition model to determine at what effectiveness and cost MIS would become cost-effective compared to usual care in terms of quality-adjusted life-years (QALYs) and direct healthcare costs. Threshold and two-way sensitivity analyses were used to determine the minimal effectiveness and maximal costs of MIS, and the most cost-effective strategy for each combination of cost and effectiveness. Scenario and probabilistic sensitivity analyses addressed model uncertainty. ResultsGiven euro10,000 of surgical costs, MIS would become cost-effective when at least 0.7-1.3% of patients improve to a modified Rankin Scale (mRS) score of 0-3 compared to usual care. When 11% of patients improve to mRS 0-3, surgical costs may be up to euro83,301-euro164,382, depending on the population studied. The cost-effectiveness of MIS was mainly determined by its effectiveness. In lower mRS states, MIS needs to be more effective to be cost-effective compared to higher mRS states. ConclusionMIS has the potential to be cost-effective in patients with spontaneous supratentorial ICH, even with relatively low effectiveness. These results support phase-III trials to investigate the effectiveness of MIS.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available